Regulatory T cells: from bench to bedside.
Regulatory T cells (Tregs) are subsets of T cells that are specifically dedicated to controlling immune responses. It has been established that Tregs play a key role in regulating autoimmune disease, allergy, cancer, infectious disease, and in the induction of transplantation tolerance. The latest progress in the development, function, mechanism of action, and homeostasis of regulatory T cells, and their translation to the clinic were presented at the International Conference on Regulatory T Cells and Clinical Application in Human Diseases in Beijing on 25-27 October 2008 (China Tregs 2008). In this Special Issue of International Immunopharmacology, several papers submitted to the China Tregs 2008 will highlight some of the recent advances in the biology of regulatory T cells and current strategies to translate regulatory T cells into the clinic.
Jiang
Shuiping
S
Shantou University Medical College, Shantou, China. shuiping.jiang@chinatregs2008.com
D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy; D035843:Biomedical Research / Q000639:trends; D002681:China; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology / Q000628:therapy; D007111:Immunity, Cellular; D007167:Immunotherapy; D007239:Infections / Q000276:immunology / Q000628:therapy; D009369:Neoplasms / Q000276:immunology / Q000628:therapy; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*; D023001:Transplantation Tolerance